Target intelligence / Profile preview

Bacterial DNA gyrase subunit A (GyrA)–DNA complex (GyrA–DNA complex)

Target
GyrA–DNA complex
Molecular classification
Enzyme, Type II topoisomerase, DNA-binding protein
01

Overview

Bacterial DNA gyrase is a fundamental enzyme in prokaryotes, belonging to the type II topoisomerase family, and is essential for maintaining DNA topology during replication, transcription, and recombination [UniProt: P0AES4]. It functions as an A2B2 heterotetramer, where the GyrA subunit is primarily responsible for the DNA breakage-reunion cycle [PMID: 20537116]. The GyrA subunit–DNA complex is the primary target for the fluoroquinolone class of antibiotics, such as ciprofloxacin and levofloxacin [StatPearls: Fluoroquinolones]. These drugs act by intercalating into the DNA at the cleavage site and stabilizing the covalent enzyme-DNA intermediate, known as the cleavable complex [PMID: 24508281]. This stabilization prevents the re-ligation of the DNA strands, leading to the accumulation of double-strand breaks and subsequent bacterial cell death. Resistance to these drugs often arises from specific mutations within the Quinolone Resistance-Determining Region (QRDR) of the GyrA subunit, which reduce drug binding affinity [PMID: 12654733].

Other names
DNA gyrase subunit AGyrATopoisomerase II subunit AQuinolone resistance-determining regionDNA gyrase A
02

Mechanism of action

Inhibition of DNA ligation by stabilizing the covalent enzyme-DNA cleavage complex, leading to double-strand DNA breaks and cell death.

03

Biological functions

DNA replicationDNA transcriptionDNA supercoilingDNA repair
04

Disease associations

Infection
05

Safety considerations

TendonitisTendon rupturePeripheral neuropathyCentral nervous system effectsAntibiotic resistanceClostridioides difficile infection
06

Interacting drugs

Ciprofloxacin

7 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)GyrA gene mutationsQRDR mutations

Beyond the preview

Go deeper on Bacterial DNA gyrase subunit A (GyrA)–DNA complex (GyrA–DNA complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial DNA gyrase subunit A (GyrA)–DNA complex (GyrA–DNA complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call